Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A

Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A

Parth Vashi,1,* Katharine Batt,2,* Robert Klamroth,3 Maria Elisa Mancuso,4 Renata Majewska,5,6 Andreas Tiede,7 Lorenzo Giovanni Mantovani8,9 1US Data Generation and Observational Studies, Bayer Corporation, Whippany, NJ, USA; 2Department of Internal Medicine, Section on Hematology/Me...

Full description

Bibliographic Details
Main Authors: Vashi P, Batt K, Klamroth R, Mancuso ME, Majewska R, Tiede A, Mantovani LG
Format: Article
Language:English
Published: Dove Medical Press 2021-11-01
Series:Journal of Blood Medicine
Subjects:
bay 94-9027
n8-gp
prophylaxis
bleed
coagulation factor viii
adults
factor viii consumption
Online Access:https://www.dovepress.com/indirect-treatment-comparison-of-damoctocog-alfa-pegol-versus-turoctoc-peer-reviewed-fulltext-article-JBM

Internet

https://www.dovepress.com/indirect-treatment-comparison-of-damoctocog-alfa-pegol-versus-turoctoc-peer-reviewed-fulltext-article-JBM

Similar Items